(Reuters) -COVID-19 vaccine maker Novavax on Thursday reported higher-than-expected revenue for the third quarter, boosted by U.S. government grants to help cover the expense of clinical trials, and … [+2406 chars]Read More
Novavax posts higherthanexpected revenue says prepared to further cut costs Yahoo Finance
